Annis Gardner Whiting Capital Advisors, LLC Apellis Pharmaceuticals, Inc. Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $279 Billion
- Q1 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 187 shares of APLS stock, worth $7,019. This represents 0.0% of its overall portfolio holdings.
Number of Shares
187Holding current value
$7,019% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
337Shares Held
111MCall Options Held
1.26MPut Options Held
1.14M-
Wellington Management Group LLP Boston, MA15.1MShares$565 Million0.16% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.4MShares$426 Million19.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$417 Million7.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.51MShares$357 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$206 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.12B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...